Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer

NCT04742192 · clinicaltrials.gov ↗
COMPLETED
Status
601
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca